Merck news from FierceHealthcare
News
FL sues Merck over Vioxx marketing
Drugmakers agree to six-month DTC delay
ALSO NOTED: FDA sending fewer warning letters;IL law would limit what hospitals can charge uninsured patients; and much more...
Merck agrees to $58M settlement on Vioxx ads
ALSO NOTED: Tenet reports $31M loss for quarter; FDA rules against broader Fentora use; and much more...
ALSO NOTED: Group pushing for Medicare e-prescribing requirement; Merck cutting sales force; and much more...
Studies show problems with four big-name drugs
Get more Merck coverage at:
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies





